Joao Quevedo
Overview
Explore the profile of Joao Quevedo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
619
Citations
10474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borba L, Freitas Filho G, de Azevedo Cardoso T, Arent C, Niero F, Pedro L, et al.
Pharmacol Rep
. 2025 Feb;
PMID: 39899256
Background: It is known that an inflammatory response plays a key role in COVID-19 pathogenesis. An exacerbated inflammatory response can increase oxidative stress in cells. This study aimed to investigate...
2.
Aguiar-Geraldo J, Canever L, Marino D, Coan C, Possamai-Della T, Pescador B, et al.
Neurotox Res
. 2025 Jan;
43(1):5.
PMID: 39833594
Given ketamine's conflicting impacts on the central nervous system, investigating its effects within an inflammatory context becomes crucial. This study aimed to assess the impact of varying ketamine doses on...
3.
de Leon V, Allen R, Quevedo J, Riva-Posse P, Aaronson S, Berger M, et al.
J Affect Disord
. 2024 Dec;
374:619-629.
PMID: 39722333
Background: Suicide attempts are a major concern in major depressive disorder (MDD), especially for those with multiple prior unsuccessful treatment trials. This report compares baseline demographic, clinical features, and treatment...
4.
Conway C, Aaronson S, Sackeim H, George M, Zajecka J, Bunker M, et al.
Brain Stimul
. 2024 Dec;
PMID: 39706521
Background: Few treatments are available for individuals with marked treatment-resistant depression (TRD). Objective: Evaluate the safety and effectiveness of FDA-approved adjunctive vagus nerve stimulation (VNS) in patients with marked TRD....
5.
Rush A, Conway C, Aaronson S, George M, Riva-Posse P, Dunner D, et al.
Brain Stimul
. 2024 Dec;
PMID: 39701918
Background: Depression treatments aim to minimize symptom burden and optimize quality of life (QoL) and psychosocial function. Objective: Compare the effects of adjunctive versus sham vagus nerve stimulation (VNS) on...
6.
Boscutti A, Asir B, Moura I, Fenoy A, Quevedo J, Soares J
Brain Stimul
. 2024 Dec;
18(1):61-63.
PMID: 39672230
No abstract available.
7.
Doifode T, Maziero M, Quevedo J, Barichello T
Methods Mol Biol
. 2024 Nov;
2868:73-90.
PMID: 39546226
The field of psychoneuroimmunology has significantly expanded in the last few decades and so has our understanding of the bidirectional communications between the immune and central nervous systems (CNS). There...
8.
Possamai-Della T, Peper-Nascimento J, Varela R, Daminelli T, Fries G, Ceretta L, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Nov;
PMID: 39540902
Childhood maltreatment may be linked to epigenetics and brain-derived neurotrophic factor (BDNF) changes, which are mechanisms altered in several psychiatric conditions, including bipolar disorder (BD). However, the specific mechanisms connecting...
9.
Carbajal-Tamez M, Monday E, Quevedo J
Trends Psychiatry Psychother
. 2024 Sep;
PMID: 39321346
No abstract available.
10.
Peper-Nascimento J, Rogers M, Madeira K, Keller G, Richards J, Ceretta L, et al.
Cien Saude Colet
. 2024 Sep;
29(10):e01862023.
PMID: 39292030
This article aims to examine differences in suicidal narrative and suicide crisis syndrome symptoms, and suicidal ideation among those who maintained, lost, and gained employment or student status during the...